Potassium chloride
Sold as Cardioplegic induction fresenius, Cardioplegic maintenance fresenius, Ultipot, Potassium chloride unicorn, Sandoz-k, Plenish-k sr, Potassium chloride b braun, Adco potassium chloride ( m/v ), Lento-k, Sterile potassium chloride, Sterile potassium chloride bp w/v, Susta-k, Potassium chloride-fresenius, Potassium chloride flexivial fresenius, Plenish k, Micro-k extencaps, Remedia potassium chloride, Adco potassium chloride
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 10
- Registrations
- 18
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fresenius Kabi Manufacturing SA (Pty) Ltd | Cardioplegic induction fresenius, Cardioplegic maintenance fresenius, Potassium chloride-fresenius | 3.757 g/500 m AND 1.375 g/500 ml, solution, 15% | 300133, 300134, L0089 | S3 | PIPIL |
| Cipla Medpro (Pty) Ltd | Ultipot | Not stated | 350370 | Not determined | None |
| Sandoz South Africa (Pty) Ltd | Potassium chloride unicorn, Sandoz-k | 600 | 360176, 360177 | Not determined | None |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited1 of 3 cancelled | Plenish-k sr, Plenish k, Micro-k extencaps | 600 mg | 520441, L0417, T0157 | S2 | PIPIL |
| B Braun Medical (Pty) Ltd | Potassium chloride b braun | 14,9 % | A390621 | Not determined | None |
| Adcock ingram limitedCancelled | Adco potassium chloride ( m/v ), Susta-k, Remedia potassium chloride | 15 %, 150 mg/ml 15 % | B0224, J0226, U0216 | Not determined | None |
| The Premier Pharmaceutical Co LtdCancelled | Lento-k, Sterile potassium chloride | 15 % | E1673, E1680 | Not determined | None |
| Medical & Hospital Supplies LtdCancelled | Sterile potassium chloride bp w/v | 15 5 | F0025 | Not determined | None |
| Fresenius Kabi South Africa (Pty) Ltd | Potassium chloride flexivial fresenius | 100 mL | L0286 | Not determined | PIL |
| Adcock Ingram Critical Care (Pty) Ltd | Adco potassium chloride | 15% | V0218 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cardioplegic induction solution fresenius EACH 500,0 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 3,757 g | 3.757 g/500 m AND 1.375 g/500 mlSolutions for infusion | 30013330/24/0133Approved 1 April 2022 | Registered | S3 | PIPIL |
| Cardioplegic maintenance solution fresenius EACH 500,0 ml SOLUTION CONTAINS : POTASSIUM CHLORIDE 1,375 g | Solution | 30013430/24/0134 | Registered | Not determined | None |
| Ultipot EACH TABLET CONTAINS POTASSIUM CHLORIDE 600,0 mg | Not listed | 35037035/24/0370 | Registered | Not determined | None |
| Potassium chloride unicorn 600 EACH TABLET CONTAINS POTASSIUM CHLORIDE 600,0 mg | 600 | 36017636/24/0176 | Registered | Not determined | None |
| Sandoz-k 600 EACH TABLET CONTAINS POTASSIUM CHLORIDE 600,0 mg | 600 | 36017736/24/0177 | Registered | Not determined | None |
| Plenish-k 600 sr EACH TABLET CONTAINS: POTASSIUM CHLORIDE 600,0 mg | 600 mgTablet | 52044152/24/0441Approved 19 February 2026 | Registered | S2 | PIPIL |
| Potassium chloride b braun 14,9 % EACH 100,0 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 14,90 g | 14,9 % | A390621A39/24/0621 | Registered | Not determined | None |
| Adco potassium chloride injection 150 mg/ml ( 15 % m/v ) * EACH 10 ml CONTAINS POTASSIUM CHLORIDE 1,5 g | 150 mg/ml 15 %Injection | B0224B/24/224 | Cancelled | Not determined | None |
| Lento-k TABLET POTASSIUM CHLORIDE A 600 MG | Not listed | E1673 | Cancelled | Not determined | None |
| Sterile potassium chloride solution 15 % 10 ML POTASSIUM CHLORIDE A 1,5 G | 15 %Solution | E1680 | Cancelled | Not determined | None |
| Sterile solution potassium chloride bp 15 5 w/v 10 ML POTASSIUM CHLORIDE 1,5 G | 15 5Solution | F0025F/24/25 | Cancelled | Not determined | None |
| Susta-k EACH TABLET CONTAINS POTASSIUM CHLORIDE 600 mg | Not listed | J0226J/24/226 | Cancelled | Not determined | None |
| Potassium chloride-fresenius 15% EACH 10,0 ml AMPOULE CONTAINS POTASSIUM CHLORIDE 1,5 g | 15% | L0089L/24/89 | Registered | Not determined | None |
| Potassium chloride 15% flexivial fresenius EACH 100 ml CONTAINS POTASSIUM CHLORIDE 15 g | 100 mLConcentrate for solution for infusion. | L0286L/24/286Approved 18 November 2024 | Registered | Not determined | PIL |
| Plenish - k EACH TABLET CONTAINS POTASSIUM CHLORIDE 600 MG | - | L0417L/24/417 | Registered | Not determined | None |
| Micro-k extencaps EACH CAPSULE CONTAINS POTASSIUM CHLORIDE 600 MG | Not listed | T0157T/24/157 | Cancelled | Not determined | None |
| Remedia potassium chloride injection 15 %* EACH 10 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 1,5 g | 15 %Injection | U0216U/24/216 | Cancelled | Not determined | None |
| Adco potassium chloride 15% EACH 10 ml SOLUTION CONTAINS POTASSIUM CHLORIDE 1,5 g | 15% | V0218V/24/218 | Registered | Not determined | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Potassium chloride
S3: Potassium
- when intended for intravenous infusion or for injection;
- except when contained in oral rehydration preparations; (S0)
- except in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours. (S2)
Consolidated Schedules 06 July 2026, lines 4148 to 4153
S2: Potassium
- in oral preparations or mixtures containing more than 20 millimoles (1500mg) of potassium per 24 hours;
- except when intended for intravenous infusion or for injection; (S3) and
- except when contained in oral rehydration preparations. (S0)
Consolidated Schedules 06 July 2026, lines 2563 to 2569
Pharmacological class: Mineral substitutes, electrolytes and trace elements (class 24)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Cardioplegic induction solution fresenius, Fresenius Kabi Manufacturing SA (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.